Cargando…
Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke
Autores principales: | Hemmings, Robert, Koch, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593771/ https://www.ncbi.nlm.nih.gov/pubmed/30900391 http://dx.doi.org/10.1002/pst.1935 |
Ejemplares similares
-
The association between subgroups of MRI findings identified with latent class analysis and low back pain in 40-year-old Danes
por: Jensen, Rikke K., et al.
Publicado: (2018) -
Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
por: Tanniou, Julien, et al.
Publicado: (2016) -
EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets – a primer for academic researchers
por: Sudlow, Rebecca, et al.
Publicado: (2016) -
Spencer
por: Rumney, Jay, 1905-
Publicado: (1944) -
Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing
por: Best, Nicky, et al.
Publicado: (2021)